Global colorectal cancer burden in 2020 and projections to 2040
Tài liệu tham khảo
Guren, 2019, The global challenge of colorectal cancer, Lancet Gastroenterol. Hepatol., 4, 894, 10.1016/S2468-1253(19)30329-2
Schreuders, 2015, Colorectal cancer screening: a global overview of existing programmes, Gut, 64, 1637, 10.1136/gutjnl-2014-309086
Schliemann, 2020, Implementation of colorectal cancer screening interventions in low-income and middle-income countries: a scoping review protocol, BMJ Open, 10, 10.1136/bmjopen-2020-037520
Rabeneck, 2020, International perspective on the burden of colorectal cancer and public health effects, Gastroenterology, 158, 447, 10.1053/j.gastro.2019.10.007
Keum, 2019, Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies, Nat. Rev. Gastroenterol. Hepatol., 16, 713, 10.1038/s41575-019-0189-8
Campos, 2017, Colorectal cancer in young adults: a difficult challenge, World J. Gastroenterol., 23, 5041, 10.3748/wjg.v23.i28.5041
Lancet, 2017, Colorectal cancer: a disease of the young?, Lancet Oncol., 18, 413, 10.1016/S1470-2045(17)30202-4
Fidler, 2017, Assessing global transitions in human development and colorectal cancer incidence, Int. J. Cancer, 140, 2709, 10.1002/ijc.30686
Arnold, 2017, Global patterns and trends in colorectal cancer incidence and mortality, Gut, 66, 683, 10.1136/gutjnl-2015-310912
Allemani, 2018, Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries, Lancet, 391, 1023, 10.1016/S0140-6736(17)33326-3
The, 2018, GLOBOCAN 2018: counting the toll of cancer, Lancet, 392, 985, 10.1016/S0140-6736(18)32252-9
Li, 2009, Colorectal cancer, one entity or three, J. Zhejiang Univ. Sci. B, 10, 219, 10.1631/jzus.B0820273
Murphy, 2019, Heterogeneity of colorectal cancer risk factors by anatomical subsite in 10 european countries: a multinational cohort study, Clin. Gastroenterol. Hepatol., 17, 1323, 10.1016/j.cgh.2018.07.030
Botteri, 2020, Smoking and colorectal cancer risk, overall and by molecular subtypes: a meta-analysis, Am. J. Gastroenterol., 115, 1940, 10.14309/ajg.0000000000000803
Crockett, 2019, Terminology, molecular features, epidemiology, and management of serrated colorectal Neoplasia, Gastroenterology, 157, 949, 10.1053/j.gastro.2019.06.041
Grady, 2008, Genomic and epigenetic instability in colorectal cancer pathogenesis, Gastroenterology, 135, 1079, 10.1053/j.gastro.2008.07.076
Xiong, 2018, Profiles of alternative splicing in colorectal cancer and their clinical significance: a study based on large-scale sequencing data, EBioMedicine, 36, 183, 10.1016/j.ebiom.2018.09.021
Seligmann, 2017, Use of gene expression profiles to distinguish molecular subtypes in colorectal cancer: progression toward primetime, J. Natl. Cancer Inst., 109, 10.1093/jnci/djx019
Jo, 2006, Chemotherapeutic implications in microsatellite unstable colorectal cancer, Cancer Biomark., 2, 51, 10.3233/CBM-2006-21-206
Loree, 2018, Classifying colorectal cancer by tumor location rather than sidedness highlights a continuum in mutation profiles and consensus molecular subtypes, Clin. Cancer Res., 24, 1062, 10.1158/1078-0432.CCR-17-2484
Sargent, 2010, Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer, J. Clin. Oncol., 28, 3219, 10.1200/JCO.2009.27.1825
Burki, 2015, Reclassifying colorectal cancer subtypes, Lancet Oncol., 16, e591, 10.1016/S1470-2045(15)00443-X
Kamal, 2019, Transcriptomic differences between primary colorectal adenocarcinomas and distant metastases reveal metastatic colorectal cancer subtypes, Cancer Res., 79, 4227, 10.1158/0008-5472.CAN-18-3945
Dienstmann, 2019, Relative contribution of clinicopathological variables, genomic markers, transcriptomic subtyping and microenvironment features for outcome prediction in stage II/III colorectal cancer, Ann. Oncol., 30, 1622, 10.1093/annonc/mdz287
Jass, 2007, Classification of colorectal cancer based on correlation of clinical, morphological and molecular features, Histopathology, 50, 113, 10.1111/j.1365-2559.2006.02549.x
Alwers, 2019, Associations Between molecular classifications of colorectal cancer and patient survival: a systematic review, Clin. Gastroenterol. Hepatol., 17, 402, 10.1016/j.cgh.2017.12.038
Singh, 2015, Immune checkpoints and immunotherapy for colorectal cancer, Gastroenterol. Rep., 3, 289
Kopetz, 2021, Randomized trial of irinotecan and cetuximab with or without vemurafenib in BRAF-mutant metastatic colorectal cancer (SWOG S1406), J. Clin. Oncol., 39, 285, 10.1200/JCO.20.01994
Van Cutsem, 2019, Binimetinib, encorafenib, and cetuximab triplet therapy for patients with BRAF V600E-mutant metastatic colorectal cancer: safety lead-in results from the phase III BEACON colorectal cancer study, J. Clin. Oncol., 37, 1460, 10.1200/JCO.18.02459
Najdi, 2011, Wnt signaling and colon carcinogenesis: beyond APC, J. Carcinog., 10, 5, 10.4103/1477-3163.78111
Phipps, 2013, KRAS-mutation status in relation to colorectal cancer survival: the joint impact of correlated tumour markers, Br. J. Cancer, 108, 1757, 10.1038/bjc.2013.118
Park, 2014, The relationship between tumour stroma percentage, the tumour microenvironment and survival in patients with primary operable colorectal cancer, Ann. Oncol., 25, 644, 10.1093/annonc/mdt593
Staudacher, 2017, Activin signaling is an essential component of the TGF-beta induced pro-metastatic phenotype in colorectal cancer, Sci. Rep., 7, 10.1038/s41598-017-05907-8
de Gramont, 2017, Novel TGF-beta inhibitors ready for prime time in onco-immunology, Oncoimmunology, 6, 10.1080/2162402X.2016.1257453
Yang, 2018, Proximal shift of colorectal cancer with increasing age in different ethnicities, Cancer Manag. Res., 10, 2663, 10.2147/CMAR.S166548
Vuik, 2019, Increasing incidence of colorectal cancer in young adults in Europe over the last 25 years, Gut, 68, 1820, 10.1136/gutjnl-2018-317592
Willauer, 2019, Clinical and molecular characterization of early-onset colorectal cancer, Cancer, 125, 2002, 10.1002/cncr.31994
Hofseth, 2020, Early-onset colorectal cancer: initial clues and current views, Nat. Rev. Gastroenterol. Hepatol., 17, 352, 10.1038/s41575-019-0253-4
Ashktorab, 2016, A meta-analysis of MSI frequency and race in colorectal cancer, Oncotarget, 76, 34546, 10.18632/oncotarget.8945
Augustus, 2018, Colorectal cancer disparity in african americans risk factors and carcinogenic mechanisms, Am. J. Pathol., 188, 291, 10.1016/j.ajpath.2017.07.023
Shin, 2012, Increasing trend of colorectal cancer incidence in Korea, 1999–2009, Cancer Res. Treat., 44, 219, 10.4143/crt.2012.44.4.219
Tian, 2019, Familial colorectal cancer risk in half siblings and siblings: nationwide cohort study, BMJ, 364, l803, 10.1136/bmj.l803
Lichtenstein, 2000, Environmental and heritable factors in the causation of cancer–analyses of cohorts of twins from Sweden, Denmark, and Finland, N. Engl. J. Med., 343, 78, 10.1056/NEJM200007133430201
Jiao, 2014, Estimating the heritability of colorectal cancer, Hum. Mol. Genet., 23, 3898, 10.1093/hmg/ddu087
Kastrinos, 2020, Use of Family history and genetic testing to determine risk of colorectal cancer, Gastroenterology, 158, 389, 10.1053/j.gastro.2019.11.029
Dong, 2017, Abdominal obesity and colorectal cancer risk: systematic review and meta-analysis of prospective studies, Biosci. Rep., 37, 10.1042/BSR20170945
Ye, 2020, Linking obesity with colorectal cancer: epidemiology and mechanistic insights, Cancers, 12, 10.3390/cancers12061408
Liu, 2019, Association of obesity with risk of early-onset colorectal cancer among women, JAMA Oncol., 5, 37, 10.1001/jamaoncol.2018.4280
Xue, 2017, Body mass index and the risk of cancer in women compared with men: a meta-analysis of prospective cohort studies, Eur. J. Cancer Prev., 26, 94, 10.1097/CEJ.0000000000000231
Kim, 2017, Sex differences in the association of obesity and colorectal cancer risk, Cancer Causes Control, 28, 1, 10.1007/s10552-016-0831-5
Bouvard, 2015, International agency for research on cancer monograph working, carcinogenicity of consumption of red and processed meat, Lancet Oncol., 16, 1599, 10.1016/S1470-2045(15)00444-1
Tabung, 2018, Association of dietary inflammatory potential with colorectal cancer risk in men and women, JAMA Oncol., 4, 366, 10.1001/jamaoncol.2017.4844
2019, The global, regional, and national burden of colorectal cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the global burden of disease study 2017, Lancet Gastroenterol. Hepatol., 4, 913, 10.1016/S2468-1253(19)30345-0
Choi, 2018, Light alcohol drinking and risk of cancer: a meta-analysis of cohort studies, Cancer Res. Treat., 50, 474, 10.4143/crt.2017.094
Chen, 2020, Novel and prevalent non-East Asian ALDH2 variants; Implications for global susceptibility to aldehydes' toxicity, EBioMedicine, 55, 10.1016/j.ebiom.2020.102753
Secretan, 2009, A review of human carcinogens-part E: tobacco, areca nut, alcohol, coal smoke, and salted fish, Lancet Oncol., 10, 1033, 10.1016/S1470-2045(09)70326-2
Hamada, 2019, Smoking and risk of colorectal cancer sub-classified by tumor-infiltrating T cells, J. Natl. Cancer Inst., 111, 42, 10.1093/jnci/djy137
Yang, 2015, Active smoking and mortality among colorectal cancer survivors: the cancer prevention study ii nutrition cohort, J. Clin. Oncol., 33, 885, 10.1200/JCO.2014.58.3831
Zeilinger, 2013, Tobacco smoking leads to extensive genome-wide changes in DNA methylation, PLoS ONE, 8, e63812, 10.1371/journal.pone.0063812
Nishihara, 2013, A prospective study of duration of smoking cessation and colorectal cancer risk by epigenetics-related tumor classification, Am. J. Epidemiol., 178, 84, 10.1093/aje/kws431
Lutgens, 2013, Declining risk of colorectal cancer in inflammatory bowel disease: an updated meta-analysis of population-based cohort studies, Inflamm. Bowel. Dis., 19, 789, 10.1097/MIB.0b013e31828029c0
Nadeem, 2020, Risk of colorectal cancer in inflammatory bowel diseases, Semin. Cancer Biol., 64, 51, 10.1016/j.semcancer.2019.05.001
Itzkowitz, 2004, Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation, Am. J. Physiol. Gastrointest. Liver Physiol., 287, G7, 10.1152/ajpgi.00079.2004
Choi, 2017, Clonal evolution of colorectal cancer in IBD, Nat. Rev. Gastroenterol. Hepatol., 14, 218, 10.1038/nrgastro.2017.1
Stjarngrim, 2019, Rates and characteristics of postcolonoscopy colorectal cancer in the Swedish IBD population: what are the differences from a non-IBD population?, Gut, 68, 1588, 10.1136/gutjnl-2018-316651
Zhang, 2019, Oral antibiotic use and risk of colorectal cancer in the United Kingdom, 1989–2012: a matched case-control study, Gut, 68, 1971, 10.1136/gutjnl-2019-318593
Dulai, 2016, Chemoprevention of colorectal cancer in individuals with previous colorectal neoplasia: systematic review and network meta-analysis, BMJ, 355, i6188, 10.1136/bmj.i6188
Liao, 2012, Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival, N. Engl. J. Med., 367, 1596, 10.1056/NEJMoa1207756
Li, 2015, Aspirin use after diagnosis but not prediagnosis improves established colorectal cancer survival: a meta-analysis, Gut, 64, 1419, 10.1136/gutjnl-2014-308260
Buskermolen, 2019, Colorectal cancer screening with faecal immunochemical testing, sigmoidoscopy or colonoscopy: a microsimulation modelling study, BMJ, 367, l5383, 10.1136/bmj.l5383
Porcellini, 2018, Epigenetic and epitranscriptomic changes in colorectal cancer: diagnostic, prognostic, and treatment implications, Cancer Lett., 419, 84, 10.1016/j.canlet.2018.01.049
Sveen, 2020, Biomarker-guided therapy for colorectal cancer: strength in complexity, Nat. Rev. Clin. Oncol., 17, 11, 10.1038/s41571-019-0241-1
Gargalionis, 2017, Liquid biopsies in colorectal cancer: monitoring genetic heterogeneity, Trends Cancer, 3, 166, 10.1016/j.trecan.2017.01.003
Wolf, 2018, Colorectal cancer screening for average-risk adults: 2018 guideline update from the American cancer society, CA Cancer J. Clin., 68, 250, 10.3322/caac.21457